Genetic analysis of innate immunity

被引:27
作者
Hoebe, Kasper [1 ]
Jiang, Zhengfan
Tabeta, Koichi
Du, Xin
Georgel, Philippe
Crozat, Karine
Beutler, Bruce
机构
[1] Scripps Res Inst, Dept Immunol, IMM31, La Jolla, CA USA
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Dept Oral Biol Sci, Niigata 9518514, Japan
[3] Fac Med, Lab Immunogenet Mol Hum, Ctr Rech Immunol & Hematol, F-67085 Strasbourg, France
来源
ADVANCES IN IMMUNOLOGY, VOL 91 | 2006年 / 91卷
关键词
D O I
10.1016/S0065-2776(06)91005-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The inflammatory response to microbes-and host perception of microbes in general-is largely initiated by a single class of receptors, named for their similarity to the prototypic Toll receptor of Drosophila. The mammalian Toll-like receptors (TLRs) are ultimately responsible for most phenomena associated with infection. This includes both "good" effects of infection (e.g., the induction of lasting specific immunity to an infectious agent) and "bad" effects of infection (systemic inflammation and shock). Although they are essential for host defense, no other endogenous proteins can match their lethal potential. The TLR complexes transduce the toxicity of lipopolysaccharide (LPS), cysteinyl lipopeptides, and many other molecules of microbial origin. The identification of the TLRs as the key conduit to host awareness of microbial infection was a victory for reductionism, proving that the complexity of infectious inflammation as a phenomenon belies the simplicity of its origins. It was achieved by a classical genetic approach, proceeding from phenotype to gene. Further analysis of the signaling pathways activated by the TLRs has depended on both classical and reverse genetic methods. Additional work will ultimately disclose the extent to which sterile inflammatory diseases are mediated by aberrations in these pathways.
引用
收藏
页码:175 / 226
页数:52
相关论文
共 241 条
[1]   An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains [J].
Aaltonen, J ;
Bjorses, P ;
Perheentupa, J ;
HorelliKuitunen, N ;
Palotie, A ;
Peltonen, L ;
Lee, YS ;
Francis, F ;
Hennig, S ;
Thiel, C ;
Lehrach, H ;
Yaspo, ML .
NATURE GENETICS, 1997, 17 (04) :399-403
[2]  
ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665
[3]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[4]  
ADYE JC, 1973, Z IMMUNITATSFORSCH, V144, P491
[5]  
Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
[6]  
2-U
[7]   Population genetics -: Malaria susceptibility and CD36 mutation [J].
Aitman, TJ ;
Cooper, LD ;
Norsworthy, PJ ;
Wahid, FN ;
Gray, JK ;
Curtis, BR ;
McKeigue, PM ;
Kwiatkowski, D ;
Greenwood, BM ;
Snow, RW ;
Hill, AV ;
Scott, J .
NATURE, 2000, 405 (6790) :1015-1016
[8]   Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: Higher affinity than that with MD-2 or CD14 [J].
Akashi, S ;
Saitoh, S ;
Wakabayashi, Y ;
Kikuchi, T ;
Takamura, N ;
Nagai, Y ;
Kusumoto, Y ;
Fukase, K ;
Kusumoto, S ;
Adachi, Y ;
Kosugi, A ;
Miyake, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) :1035-1042
[9]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[10]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738